FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004644402> ?p ?o ?g. }

• W2004644402 endingPage "5808" @default.
• W2004644402 startingPage "5808" @default.
• W2004644402 abstract "Pancreatic ductal adenocarcinoma (PDA) is a devastating disease with pronounced morbidity and a high mortality rate. Currently available treatments lack convincing cost-efficiency determinations and are in most cases not associated with relevant success rate. Experimental stimulation of the immune system in murine PDA models has revealed some promising results. Toll-like receptors (TLRs) are pillars of the immune system that have been linked to several forms of malignancy, including lung, breast and colon cancer. In humans, TLRs are expressed in the pancreatic cancer tissue and in several cancer cell lines, whereas they are not expressed in the normal pancreas. In the present review, we explore the current knowledge concerning the role of different TLRs associated to PDA. Even if almost all known TLRs are expressed in the pancreatic cancer microenvironment, there are only five TLRs suggested as possible therapeutic targets. Most data points at TLR2 and TLR9 as effective tumor markers and agonists could potentially be used as e.g. future adjuvant therapies. The elucidation of the role of TLR3 in PDA is only in its initial phase. The inhibition/blockage of TLR4-related pathways has shown some promising effects, but there are still many steps left before TLR4 inhibitors can be considered as possible therapeutic agents. Finally, TLR7 antagonists seem to be potential candidates for therapy. Independent of their potential in immunotherapies, all existing data indicate that TLRs are strongly involved in the pathophysiology and development of PDA." @default.
• W2004644402 created "2016-06-24" @default.
• W2004644402 creator A5018022592 @default.
• W2004644402 creator A5054165373 @default.
• W2004644402 date "2014-01-01" @default.
• W2004644402 modified "2023-10-16" @default.
• W2004644402 title "Intervention on toll-like receptors in pancreatic cancer" @default.
• W2004644402 cites W1492569216 @default.
• W2004644402 cites W1514540900 @default.
• W2004644402 cites W1547700789 @default.
• W2004644402 cites W1838354729 @default.
• W2004644402 cites W1931508686 @default.
• W2004644402 cites W1950891144 @default.
• W2004644402 cites W1964196894 @default.
• W2004644402 cites W1966490934 @default.
• W2004644402 cites W1970539851 @default.
• W2004644402 cites W1971052438 @default.
• W2004644402 cites W1971901683 @default.
• W2004644402 cites W1972107031 @default.
• W2004644402 cites W1977957999 @default.
• W2004644402 cites W1983419107 @default.
• W2004644402 cites W1987065573 @default.
• W2004644402 cites W1990142540 @default.
• W2004644402 cites W1992156947 @default.
• W2004644402 cites W1994809784 @default.
• W2004644402 cites W1995308143 @default.
• W2004644402 cites W1998143989 @default.
• W2004644402 cites W1999182967 @default.
• W2004644402 cites W2000635259 @default.
• W2004644402 cites W2007751980 @default.
• W2004644402 cites W2011102827 @default.
• W2004644402 cites W2011982648 @default.
• W2004644402 cites W2017349266 @default.
• W2004644402 cites W2017742161 @default.
• W2004644402 cites W2025756257 @default.
• W2004644402 cites W2026798969 @default.
• W2004644402 cites W2028166777 @default.
• W2004644402 cites W2031075581 @default.
• W2004644402 cites W2032298238 @default.
• W2004644402 cites W2043367201 @default.
• W2004644402 cites W2045318794 @default.
• W2004644402 cites W2049800909 @default.
• W2004644402 cites W2051912261 @default.
• W2004644402 cites W2051940924 @default.
• W2004644402 cites W2053479613 @default.
• W2004644402 cites W2054683516 @default.
• W2004644402 cites W2054870962 @default.
• W2004644402 cites W2055703363 @default.
• W2004644402 cites W2056840717 @default.
• W2004644402 cites W2061905705 @default.
• W2004644402 cites W2065192736 @default.
• W2004644402 cites W2068047918 @default.
• W2004644402 cites W2075792687 @default.
• W2004644402 cites W2076098855 @default.
• W2004644402 cites W2088233050 @default.
• W2004644402 cites W2092741446 @default.
• W2004644402 cites W2096961265 @default.
• W2004644402 cites W2098253706 @default.
• W2004644402 cites W2109636091 @default.
• W2004644402 cites W2112610954 @default.
• W2004644402 cites W2115185894 @default.
• W2004644402 cites W2120211786 @default.
• W2004644402 cites W2120509389 @default.
• W2004644402 cites W2124521982 @default.
• W2004644402 cites W2128510787 @default.
• W2004644402 cites W2134538505 @default.
• W2004644402 cites W2140634848 @default.
• W2004644402 cites W2140724157 @default.
• W2004644402 cites W2142824927 @default.
• W2004644402 cites W2143579252 @default.
• W2004644402 cites W2144356451 @default.
• W2004644402 cites W2144409317 @default.
• W2004644402 cites W2147100699 @default.
• W2004644402 cites W2147420866 @default.
• W2004644402 cites W2149336558 @default.
• W2004644402 cites W2152832279 @default.
• W2004644402 cites W2153042210 @default.
• W2004644402 cites W2155189404 @default.
• W2004644402 cites W2156788946 @default.
• W2004644402 cites W2157205294 @default.
• W2004644402 cites W2161419307 @default.
• W2004644402 cites W2161817637 @default.
• W2004644402 cites W2163090789 @default.
• W2004644402 cites W2166586819 @default.
• W2004644402 cites W2415537220 @default.
• W2004644402 cites W2469065915 @default.
• W2004644402 cites W3134530972 @default.
• W2004644402 cites W82870839 @default.
• W2004644402 doi "https://doi.org/10.3748/wjg.v20.i19.5808" @default.
• W2004644402 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4024790" @default.
• W2004644402 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24914341" @default.
• W2004644402 hasPublicationYear "2014" @default.
• W2004644402 type Work @default.
• W2004644402 sameAs 2004644402 @default.
• W2004644402 citedByCount "40" @default.
• W2004644402 countsByYear W20046444022014 @default.
• W2004644402 countsByYear W20046444022015 @default.
• W2004644402 countsByYear W20046444022016 @default.

• next